Hepatic arterial infusion chemo outdoes sorafenib for advanced liver cancer
02 Jul 2021
byAudrey Abella
Hepatic arterial infusion chemotherapy consisting of a FOLFOX* regimen (HAIC-FO) showed superior efficacy over sorafenib in the first-line treatment of locally advanced or unresectable hepatocellular carcinoma (HCC), according to the findings of the phase III FOHAIC-1 study presented at ASCO 2021.
